(20 QUESTIONS AND CORRECT ANSWERS) |
ALREADY GRADED A+ | 100% VERIFIED
Emergency Medical Technician (EMT) | Key Domains: Cardiology and Resuscitation, Acute
Coronary Syndromes, AED Use, CPR, Cardiac Arrest Management, Hemorrhagic and
Cardiogenic Shock, and NREMT Standards | Expert-Aligned Structure | Exam-Ready Format
Introduction
This structured EMT FISDAP Cardiology Exam format for 2026–2027 provides the
complete layout for generating high-quality exam-style questions with correct answers and
rationales. It emphasizes prehospital cardiac care, rapid patient assessment, resuscitation
protocols, and NREMT standards critical to professional EMS practice and successful
national certification.
Answer Format
All correct answers must appear in bold and cyan, accompanied by concise rationales
explaining safety/clinical reasoning, code adherence, and why alternative options are less
appropriate.
,Question 1: You are treating a 58-year-old male complaining of severe, crushing substernal
chest pain radiating to his left jaw and arm. He has a prescription for sublingual nitroglycerin.
His vital signs are HR 92 bpm, BP 138/84 mmHg, and SpO2 97% on room air. Before assisting
him with his nitroglycerin, what critical medication history must you verify to prevent a
catastrophic drug interaction?
A. Confirm whether he has taken a daily baby aspirin within the last 24 hours
B. Confirm whether he has taken any phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil,
tadalafil, vardenafil) for erectile dysfunction or pulmonary hypertension within the past 24 to
48 hours
C. Confirm whether he is allergic to sulfa drugs or penicillin antibiotics
D. Confirm whether he has a history of asthma requiring an albuterol inhaler
Correct Answer: B. Confirm whether he has taken any phosphodiesterase-5 (PDE-5)
inhibitors (e.g., sildenafil, tadalafil, vardenafil) for erectile dysfunction or pulmonary
hypertension within the past 24 to 48 hours
Rationale: Sublingual nitroglycerin is a potent vasodilator used to treat ischemic chest pain
by dilating coronary and peripheral vessels, which reduces cardiac preload and afterload.
Phosphodiesterase-5 (PDE-5) inhibitors (such as sildenafil [Viagra], tadalafil [Cialis], or
vardenafil [Levitra]) are also potent vasodilators. Co-administering nitroglycerin within 24
hours of sildenafil/vardenafil (or 48 hours of tadalafil) causes profound, synergistic cGMP
accumulation resulting in severe, refractory, life-threatening hypotension and potential
cardiac arrest. Aspirin (option A) is indicated for ACS and is safe with nitroglycerin.
Sulfa/penicillin allergies (option C) and asthma (option D) are not contraindications for
nitroglycerin.
Question 2: You are assessing a 65-year-old female complaining of chest pressure and
shortness of breath. Her blood pressure is 92/60 mmHg, and heart rate is 112 bpm. She asks
you to help her take her prescribed sublingual nitroglycerin tablet. According to national EMT
protocols, how should you manage this request?
A. Administer one sublingual nitroglycerin tablet under her tongue and recheck blood
pressure in 5 minutes
B. Administer half of a nitroglycerin tablet to account for her lower blood pressure
C. Withhold the nitroglycerin entirely because her systolic blood pressure is below the
mandatory national protocol safety threshold of 100 mmHg
D. Administer the nitroglycerin only after placing her in the Trendelenburg position
Correct Answer: C. Withhold the nitroglycerin entirely because her systolic blood
pressure is below the mandatory national protocol safety threshold of 100 mmHg
Rationale: According to NREMT and national EMT scope of practice standards, an absolute
contraindication for assisting a patient with sublingual nitroglycerin is a systolic blood
pressure less than 100 mmHg (or <90 mmHg in some local medical direction protocols, but
100 mmHg is the universal textbook safety baseline). Nitroglycerin dilates blood vessels and
, decreases venous return to the heart, which lowers blood pressure. Administering
nitroglycerin to a patient with a systolic blood pressure of 92 mmHg will precipitate acute,
severe vascular collapse and shock. Halving tablets (option B) or using Trendelenburg
(option D) are unsafe, unauthorized practices. Option A violates basic pharmacological safety
protocols.
Question 3: A 52-year-old male presents with acute substernal chest pain and diaphoresis. You
decide to administer oral aspirin according to your standing orders. What is the correct EMT
dosage range for aspirin in suspected Acute Coronary Syndrome (ACS), and what is its specific
pharmacological mechanism of action?
A. 81 mg to 162 mg swallowed whole; acts as a direct coronary vasodilator to open blocked
arteries
B. 162 mg to 324 mg (2 to 4 low-dose 81 mg chewable tablets) chewed and swallowed; acts
as an antiplatelet agent by inhibiting platelet aggregation (clumping), preventing the existing
coronary thrombus from enlarging
C. 500 mg to 1000 mg swallowed whole; acts as a powerful analgesic to relieve ischemic chest
pain
D. 324 mg dissolved in water; acts as a fibrinolytic agent to actively dissolve and break up the
existing blood clot
Correct Answer: B. 162 mg to 324 mg (2 to 4 low-dose 81 mg chewable tablets) chewed
and swallowed; acts as an antiplatelet agent by inhibiting platelet aggregation
(clumping), preventing the existing coronary thrombus from enlarging
Rationale: In suspected Acute Coronary Syndrome (ACS / myocardial infarction), the
standard national EMT standing order dosage for aspirin is 162 mg to 324 mg (typically two
to four 81 mg baby aspirin tablets). The tablets must be chewed by the patient to accelerate
buccal and gastric absorption. Aspirin is a cyclooxygenase (COX-1) inhibitor that blocks the
synthesis of thromboxane A2. This severely impedes platelet aggregation (clumping) for the
lifespan of the platelet, preventing the existing occlusive coronary artery thrombus from
expanding. Aspirin is NOT a vasodilator (option A) nor a fibrinolytic 'clot buster' (option D; it
cannot dissolve existing clots). High analgesic doses (option C) are unnecessary and increase
gastric bleeding risk.